The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2R,3R,4S)-2-(((R)-2-((2-fluorophenoxy)methoxy)-1-phenylethylamino)methyl)pyrrolidine-3,4-diol ID: ALA2206820
PubChem CID: 71455988
Max Phase: Preclinical
Molecular Formula: C20H25FN2O4
Molecular Weight: 376.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O[C@H]1[C@@H](O)CN[C@@H]1CN[C@@H](COCOc1ccccc1F)c1ccccc1
Standard InChI: InChI=1S/C20H25FN2O4/c21-15-8-4-5-9-19(15)27-13-26-12-17(14-6-2-1-3-7-14)22-10-16-20(25)18(24)11-23-16/h1-9,16-18,20,22-25H,10-13H2/t16-,17+,18+,20-/m1/s1
Standard InChI Key: FYORRKSEMNGZQH-DOADOZAASA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
11.3770 -28.9389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5599 -28.9496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3158 -29.7296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9850 -30.2030 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6374 -29.7123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8495 -28.2721 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0717 -28.2943 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4179 -29.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0177 -29.3992 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7983 -29.6412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3981 -29.0862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1786 -29.3282 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9790 -30.4381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3794 -30.9891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5596 -31.7854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3409 -32.0280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9420 -31.4682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7587 -30.6740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7785 -28.7732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5977 -27.9762 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8172 -27.7342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6401 -26.9388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8603 -26.6968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2596 -27.2520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4438 -28.0525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2233 -28.2909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2411 -26.3851 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
1 6 1 6
2 7 1 6
5 8 1 1
8 9 1 0
10 9 1 1
10 11 1 0
11 12 1 0
10 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
12 19 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
22 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 376.43Molecular Weight (Monoisotopic): 376.1798AlogP: 1.20#Rotatable Bonds: 9Polar Surface Area: 82.98Molecular Species: BASEHBA: 6HBD: 4#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.35CX Basic pKa: 9.13CX LogP: 1.70CX LogD: -0.03Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.39Np Likeness Score: 0.08
References 1. Moorthy NS, Brás NF, Ramos MJ, Fernandes PA.. (2012) Virtual screening and QSAR study of some pyrrolidine derivatives as α-mannosidase inhibitors for binding feature analysis., 20 (24): [PMID:23151473 ] [10.1016/j.bmc.2012.10.011 ]